News About: Pharm. Industry


Bayer Suspends Sale of Baycol, Cholesterol Lowering Drug

Bayer Korea announced on August 9 that the sale of its cholesterol lowering drug Baycol, which was placed on sale back in November 1999, was suspended in Korea. The decision to halt the sale of Baycol, issued from ...

Novartis Offers Glivec for Free

Novartis Korea has attracted considerable attention for their proposal to the Ministry of Health and Welfare to distribute free Glivec, a drug for treating chronic marrow type of leukemia to poor patients. Novarti...

Bio-engineering drugs U$100 million of overseas sales by 2003.

National overall commodity export in July has shown a sharp plunge, which was the worst figure in its historical record. To overcome this deadlock the government held an economic ministerial meeting and made it cle...

Bioequivalent test items flock to specific ingredients.

It was found that the drugs completed with its bio-equivalent test and to be booked on the Common Prescription List with priority had been concentrated on specific ingredients, which may trigger a severe competition i...

Foreign companies enjoyed brisk business after reform program.

It was found that the foreign multinational drug companies most enjoyed their pharmaceutical business after the government's medical reform program being launched. The KFDA statistics showed that the total producti...

Sales of Leading Pharmaceutical Companies Increase by 20%

Preliminary results of the pharmaceutical industry's performance based on December 2000 data show that sales of leading pharmaceutical manufacturers increased by 19.4% during the first half of this year, w...

Top 100 Korea Pharmaceutical Manufactures' Actual Output

Download

All efforts to pour into prescription drug list.

As the revised pharmaceutical affairs law was already enforced and the determination of prescription drugs at all medical institutes proceeded into a main phase from August, most of small and medium sized drug compani...

Manufactured Medicine Imports Continue to Surge in First Half

Imports of manufactured medicine over US$500,000 continue to show an increasing trend, rising to US$150.71 million in the first half of this year, up slightly from the same period last year. The trend is attributed...

Opposition to Revision of Actual Transaction Redemption System

The Korea Pharmaceutical Association has made a firm stand opposing the proposed revision of the actual transaction redemption system, invoking one's right to live and saying that it is a dangerous concept that could ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.